Fierce Pharma

FEBRUARY 8, 2024

This week on “The Top Line,” we explore the most anticipated drug launches of 2024. This week on “The Top Line,” we explore the most anticipated drug launches of 2024.

Pharma 190

Pharma Sales Marketing 190

Fierce Pharma

MARCH 7, 2024

Despite weathering a host of launch challenges with Leqembi, Eisai still has big hopes for its amyloid-busting antibody in early Alzheimer’s disease. | In the near term, the company is dealing with some launch hurdles. Come fiscal year 2032, those sales could potentially swell to a whopping 1.3 trillion yen ($8.8 trillion yen ($8.8

Sales 211

Sales 211

Fierce Pharma

OCTOBER 4, 2023

Boehringer Ingelheim, which recently launched the first interchangeable biosimilar to AbbVie’s megablockbuster Humira, is getting in on the industry’s double-pricing trick.

262

262

Fierce Pharma

MARCH 11, 2024

Nevertheless, Viatris said the snub shouldn’t weigh on its revenue guidance—and it still expects to net upwards of $550 million from new drug launches this year.

FDA 243

FDA 243

Fierce Pharma

FEBRUARY 14, 2024

Sage Therapeutics and Biogen may not have the broad label that they had hoped for with Zurzuvae, but the two companies are still touting the med’s initial launch performance in postpartum depressio | Sage Therapeutics and Biogen may not have the broad label that they had hoped for with Zurzuvae, but the two companies are touting the med’s initial launch (..)

FDA 192

FDA 192

Pharmaceutical Technology

APRIL 18, 2024

Outrun Therapeutics announced its launch with $10m seed funding to advance a protein stabilisation pipeline focused on E3 ligase inhibitors.

129

129

Fierce Pharma

JANUARY 30, 2024

After 'bad launch' remark by CEO, Pfizer's RSV vaccine gains traction in Q4. How will it fare in latest round of GSK showdown? kdunleavy Tue, 01/30/2024 - 08:58

293

293

Fierce Pharma

MARCH 28, 2024

[Yangzhou, China - March 26, 2024] - Aurisco Pharmaceutical, a leading global pharmaceutical company, is excited to announce the completion of its investment in cGMP peptide manufacturing capacity | Aurisco Pharmaceutical Launches State-of-the-Art Manufacturing Facility for GLP-1 Peptides

Manufacturing 148

Manufacturing Pharmaceutical Leads 148

Fierce Pharma

NOVEMBER 6, 2023

As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations zbecker Mon, 11/06/2023 - 20:59

291

291

Fierce Pharma

DECEMBER 19, 2023

Without that voucher, bluebird is moving fast to try to fund its launches. Despite bluebird bio winning a recent FDA nod for its muc | Bluebird's FDA approval for sickle cell disease gene therapy Lyfgenia left something to be desired because the agency rejected a request for a priority review voucher.

FDA 242

FDA 242

Fierce Pharma

MARCH 5, 2024

commercialization partner, Eyenovia, is gearing up for a launch. | Taiwan’s Formosa Pharmaceuticals has gained an FDA approval for a reformulation of a decades-old corticosteroid. With that, the company's U.S.

FDA 173

FDA Pharmaceutical 173

Fierce Pharma

APRIL 21, 2023

In heavyweight obesity fight, Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy aliu Fri, 04/21/2023 - 22:35

363

363

Fierce Pharma

DECEMBER 21, 2023

As the launch gains steam, that demand could result in a supply bottleneck, he figures.

Doctors 276

Doctors Pharmaceutical Patients 276

Fierce Pharma

OCTOBER 31, 2023

As COVID revenues dwindle for pandemic stalwart Pfizer, the company is turning attention to its respiratory syncytial virus (RSV) vaccine launch and a potential entry into the hot obesity market.

Marketing 231

Marketing 231

World of DTC Marketing

APRIL 5, 2022

The old model of looking at performance in the first six months of product launch isn’t relevant. Today, colossal budget product launches are not returning the same ROI as before. Product launches are going to need to be micro-targeted to specific audiences. What is the definition of a successful pharma product launch?

Pharma 196

Pharma Marketing Doctors Physicians 196

Fierce Pharma

JANUARY 9, 2023

JPM23, Day 1: BMS touts new launches as patent cliff looms; Regeneron's Eylea sales disappoint. esagonowsky. Mon, 01/09/2023 - 09:55.

Sales 339

Sales 339

Fierce Pharma

OCTOBER 18, 2023

After launch limitations, Johnson & Johnson exec touts manufacturing progress on CAR-T drug Carvykti fkansteiner Wed, 10/18/2023 - 14:44

Manufacturing 225

Manufacturing 225

Fierce Pharma

MARCH 19, 2024

Now, the company looks to support the upcoming launch by selling shares. . | Madrigal's Rezdiffra became the first drug approved to treat metabolic dysfunction-associated steatohepatitis (MASH) just a few days ago.

Sales 130

Sales FDA Pharmaceutical 130

Fierce Pharma

AUGUST 30, 2023

After settling a patent case with Vivitrol maker Alkermes, Teva has gained a license to launch its generic version of the opioid dependence and alcohol dependence med years ahead of the drug's pate | Under the patent settlement, Teva will be able to launch its generic two years ahead of the 2029 patent expiration for Vivitrol.

190

190

Fierce Pharma

APRIL 26, 2023

Will Nestlé be around to help Seres with the launch? FDA approves first oral microbiome therapy Vowst. aliu Wed, 04/26/2023 - 11:30

FDA 314

FDA 314

Fierce Pharma

AUGUST 28, 2023

Amid supply problems, Novo Nordisk plans to launch its GLP--1 drugs in “more and more” countries, CEO Lars Fruergaard Jørgensen said at a recent Reuters event, though he added that the launches will be "constrained."

Medicine 218

Medicine 218

Fierce Pharma

JULY 27, 2023

With generics of the popular ADHD medication Vyvanse circling the gates, Takeda will have to depend on newer launches to grow going forward.

Medical 185

Medical Marketing 185

Fierce Pharma

APRIL 18, 2024

And its top priority is the launch of a chikungunya vaccine.

Manufacturing 148

Manufacturing 148

Fierce Pharma

JUNE 1, 2023

After winning FDA approvals one month apart, Pfizer and GSK are set to launch competing RSV vaccines this fall. About a month after GSK won the world's first approval for a respiratory syncytial virus (RSV) vaccine, rival Pfizer has followed suit.

FDA 246

FDA 246

Fierce Pharma

JULY 31, 2023

For Apellis Pharmaceuticals, the emergence of rare but serious side effects has cast a pall over the launch of the company’s geographic atrophy med Syfovre. While touting the “strong commercial execution” of Syfovre’s launch, Apellis’ CEO Cedric Francois, M.D.,

Side effects 181

Side effects Safety Pharmaceutical 181

Tribeca Knowledge

FEBRUARY 9, 2023

I n our latest report, Launch Readiness 2023, we look at the prospects and challenges for new medicines entering the market in the shadow of COVID-19. We explain how digital transformation and agile launch software can help companies track, manage and align their launch activities in real-time, across functions and markets.

Pharma 97

Pharma Prospecting Medicine Marketing 97

Fierce Pharma

JANUARY 10, 2023

JPM23, Day 2: Takeda readies for dengue vaccine launch; Merck touts recent deals. Tue, 01/10/2023 - 06:24.

289

289

Fierce Pharma

APRIL 27, 2023

Bristol's multiple new launches won't stop it from scouting for M&A deals, CEO says aliu Thu, 04/27/2023 - 10:16

277

277

Fierce Pharma

AUGUST 8, 2023

First, it’s hoping new launches will help keep its doors open over the next 12 months. After closing shop in Europe two years ago, bluebird bio still aims to become an industry-leading gene therapy maker in the U.S. Bluebird aims to become an industry-leading gene therapy maker.

Leads 198

Leads FDA 198

Fierce Pharma

JANUARY 11, 2023

Lilly, Biogen and more gear up for blockbuster launches in 2023: report. Wed, 01/11/2023 - 10:19.

271

271

Fierce Pharma

JUNE 28, 2023

With a spring approval in hand, Reata Pharmaceuticals has been waiting patiently to launch its first commercial product, Skyclarys. After an FDA thumbs up on Reata's approval supplement for Skyclarys, analysts feel confident the newly commercial-stage company can meet—or potentially even exceed—a $45.9 million sales target for 2023.

FDA 217

FDA Sales Pharmaceutical Patients 217

Fierce Pharma

JANUARY 6, 2023

With Leqembi approval in Alzheimer's disease, Eisai and Biogen plot 'meticulous' launch. fkansteiner. Fri, 01/06/2023 - 12:44.

237

237

Fierce Pharma

MAY 23, 2023

Amid high-profile injectable launch, Novo Nordisk scores with its pill version of obesity drug Wegovy kdunleavy Tue, 05/23/2023 - 10:34

241

241

MedCity News

APRIL 23, 2024

The post Why Headspace Is Launching Direct-to-Consumer Services appeared first on MedCity News. Headspace is going toe-to-toe with the likes of Talkspace and BetterHelp by bringing its mental health services directly to consumers — starting with text-based mental health coaching.

67

67

Fierce Pharma

MARCH 21, 2023

As approvals roll in, Takeda details pricing strategy for dengue vaccine launch zbecker Tue, 03/21/2023 - 10:40

233

233